The Goodlife Story
What We Do
Goodlife Access launched operations in 2023 in Rwanda. We work in partnership with others to identify crucial health needs, design interventions, and embed those into sustainable models - all while using data to continually refine our work. Working in Rwanda is an excellent environment for public health: the government has made a long term commitment to data-driven investments in health and wellness, addressing the root causes of disease, and encouraging the private sector.
Our Approach
Identify crucial health needs.
|
Work in partnership to design & deliver top-quality interventions.
|
Build concrete business cases for sustaining our impact.
|
Integrate programs into sustainable channels.
|
Our Initiatives
|
Women and GirlsEnding the “period poverty” that causes one in five Rwandan girls to miss school.
We partner with community-based organizations to bring together subsidized distribution of pads with education on menstruation and broader sexual & reproductive health.
|
|
Non-Communicable Disease ReductionStemming the growing burden of NCDs like diabetes & heart disease through early detection.
We provide free NCD screening to hundreds of people each week. We will work with the Government of Rwanda and other partners to further scale community-level screening through our own facilities and other channels, with referrals for those identified as at-risk.
|
|
Expanding Rural & Low-Income ReachReaching all 30 districts of Rwanda through new approaches to delivering care.
We are out in the community every day. We develop new models for cost-effective primary care coverage via mobile clinic services, addressing gaps in access among the rural poor.
|
|
Accelerating InnovationShortening the unacceptable lag time between the development of health innovations and their availability in contexts like Rwanda.
We work with a range of product development partners to build a go-to platform for scaling innovations, from low-cost ultrasound, to targeted therapies, to novel point-of-care diagnostics, to bringing AI-enabled data systems for case management, to deploying new vaccines like RSV.
|